Search
for

    Research 10 of 58

    1. Alopecia Areata and Dexamethasone Mini-Pulse Therapy, A Prospective Cohort: Real World Evidence and Factors Related to Successful Response Journal of Clinical Medicine · 2022 · 16 citations
    2. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
    3. 598 Response to ritlecitinib treatment based on salt improvement scores in patients with alopecia areata (AA): Post hoc analysis of the allegro phase 2b/3 study 2023
    4. Tissue Retinol‐Binding Protein 4 Expression and Its Genetic Variants (rs3758539) in Patients With Severe and Treatment‐Refractory Alopecia Areata: Association With Response to Baricitinib Dermatologic Therapy · 2026
    5. Journal of Population Therapeutics and Clinical Pharmacology 2025
    6. Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study Journal of the European Academy of Dermatology and Venereology · 2025 · 15 citations
    7. Therapeutic Burden as Predictor of Response to Baricitinib for Alopecia Areata in Real Life: Prospective Study Dermatology and Therapy · 2025
    8. Baricitinib for the Treatment of Alopecia Areata Drugs · 2023 · 6 citations
    9. Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population Dermatologic Therapy · 2022 · 2 citations
    10. Long‐term efficacy and safety of baricitinib in patients with severe alopecia areata: 104‐week results from BRAVE‐AA1 and BRAVE‐AA2 Journal of the European Academy of Dermatology and Venereology · 2024
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →